Friday 6 November 2026 Export NVS’s income statement to Excel — free account

Novartis AG

NVS Healthcare Drug Manufacturers General

Novartis AG’s revenue for fiscal 2025 (year ended December 2025) was $56.7 billion, up 9.57% from fiscal 2024.

Revenue: +4.67%
EPS: −69.1%
Free cash flow: −17.8%
Total debt: +53.9%

Quarter to September 2026, against a year earlier

162.04 2.94 −1.78%

Follow NVS

Alert me

Market cap: $296.4B
P/E: 30.9×
Fwd P/E: 23.2×
Dividend yield: 2.93%
F-score: 8/9
Altman Z: 4.13
Beneish M: −2.49
Dividend safety: 66/100

Overview

Novartis AG (NVS) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Novartis AG (NVS) trades at a P/B ratio of 8.2×. Over the past ten years it has ranged from 2.0× (February 2016) to 8.3× (November 2026); the current reading is higher than 100% of that period. That is above the Drug Manufacturers General industry median of 5.2× and above the Healthcare sector median of 2.3×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/NVS/pb-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Novartis AG P/B ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/NVS/metrics/pb-ratio">Novartis AG (NVS) P/B ratio — stockrow.com</a></p>

Period	P/B ratio	Change
FY2025	5.7×	29.05%
FY2024	4.5×	(0.82%)
FY2023	4.5×	37.04%
FY2022	3.3×	17.00%
FY2021	2.8×	(23.76%)
FY2020	3.7×	(2.84%)
FY2019	3.8×	54.45%
FY2018	2.4×	(5.52%)
FY2017	2.6×	15.92%
FY2016	2.2×	(7.01%)

Period	P/B ratio	Change
Sep 2026	7.2×	1.10%
Jun 2026	7.1×	(4.98%)
Mar 2026	7.5×	30.44%
Dec 2025	5.7×	4.06%
43 more quarters	Free account

Against its own ten years

Low 2.0× High 8.3×

Ten-year median 3.4×

Current reading's percentile 100

Company	P/B ratio
ABBV AbbVie Inc. compare	n/m
PFE Pfizer Inc. compare	1.9×
NVO Novo Nordisk A/S compare	5.2×
AZN AstraZeneca PLC compare	5.6×
JNJ Johnson & Johnson compare	8.1×
NVS Novartis AG	8.2×
MRK Merck & Co., Inc. compare	8.6×
GILD Gilead Sciences, Inc. compare	16.1×
AMGN Amgen Inc. compare	21.4×
Drug Manufacturers General industry median	5.2×
Healthcare sector median	2.3×
Market median	1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

Novartis AG (NVS) P/B ratio

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on NVS

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on NVS

Stockrow Weekly